RGC
Regencell Bioscience Holdings Ltd
6.30$
+1.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.6% | +24.4% | -5.5% | -0.1% | -100.1% | – | – | – | – | – | – | |
| – | +3.7% | +2.3% | +6.4% | +10.4% | -100.0% | +0.0% | +178.0% | +2,184.5% | +27.3% | -3.1% | -47.3% | |
| – | +1.1% | -11.7% | +6.0% | +4.5% | – | – | – | – | -66.3% | -51.7% | -45.5% | |
| – | – | – | – | – | – | +0.0% | +0.0% | -5.4% | – | – | – | |
| – | – | – | -289.9% | – | – | – | +624.9% | -285.2% | – | – | – | |
| – | +39.9% | +18.4% | +15.7% | +16.5% | -100.0% | +0.0% | -100.0% | +78,087,500.0% | -96.5% | -80.4% | +2,740.3% | |
| – | – | – | – | – | – | +0.0% | +9,049.0% | 0.0% | – | +8,789.1% | -48.8% | |
| – | +123.0% | -52.8% | -0.1% | +0.0% | – | – | – | – | – | – | – | |
| – | -47.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +105.4% | -38.1% | -170.6% | -100.0% | – | – | |
| – | -499.5% | -46.3% | -10.4% | -89.4% | – | +105.4% | -55.5% | +4,995.1% | -99.4% | -24.2% | – | |
| – | -177.3% | – | -62.9% | -165.8% | – | +59.6% | -328.0% | – | -176.3% | – | -138.8% | |
| – | -18.1% | +29.3% | -21.4% | -18.5% | -100.2% | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.